Experienced the operation negatively · Patients with atrophic (resorbed) mandibles needing implants
Inlay/interposed bone graft (iliac or Bio-Oss block) + longer… showed no clear difference in experienced the operation negatively compared with short implants (8 to 11 mm) without augmentation; GRADE not reported.
1 finding from 1 review
No improvement of facial appearance (3 weeks) · Patients with atrophic (resorbed) mandibles needing implants
Inlay/interposed bone graft (iliac or Bio-Oss block) + longer… led to lower no improvement of facial appearance (3 weeks) compared with short implants (8 to 11 mm) without augmentation; GRADE not reported.
1 finding from 1 review
Prosthetic failure (2 years) · Patients with atrophic (resorbed) mandibles needing implants
Inlay/interposed bone graft (iliac or Bio-Oss block) + longer… showed no clear difference in prosthetic failure compared with short implants (8 to 11 mm) without augmentation; GRADE not reported.
1 finding from 1 review
Major complications · Patients with atrophic (resorbed) mandibles needing implants
Inlay/interposed bone graft (iliac or Bio-Oss block) + longer… led to higher major complications compared with short implants (8 to 11 mm) without augmentation; GRADE not reported.
1 finding from 1 review
Implant failure · Patients with atrophic (resorbed) mandibles needing implants
Inlay/interposed bone graft (iliac or Bio-Oss block) + longer… showed no clear difference in implant failure compared with short implants (8 to 11 mm) without augmentation; GRADE not reported.
1 finding from 1 review
Clinical improvement ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
Surgery probably leads to higher clinical improvement ‐ Long‐term improvement: > 3 months compared with splint (moderate certainty).
1 finding from 1 review
Function ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
1 finding from 1 review
Pain VAS 0‐100 (higher means worse) · carpal tunnel syndrome
1 finding from 1 review
Health‐related quality of life ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
CTS symptoms (Boston CTS questionnaire) ‐ long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · carpal tunnel syndrome
1 finding from 1 review
Function (Boston CTS questionnaire) ‐ Long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · carpal tunnel syndrome
1 finding from 1 review
Pain ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life (EQ‐5D) ‐ Long‐term improvement: > 3 months Scale: 0 to 1, higher is better · carpal tunnel syndrome
1 finding from 1 review
Clinical improvement ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
It is very uncertain whether surgery changes clinical improvement ‐ Long‐term improvement: > 3 months compared with corticosteroid injection (very low certainty).
1 finding from 1 review
Symptoms ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
1 finding from 1 review
Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care
It is very uncertain whether smoking cessation counselling changes quit at longest compared with no smoking cessation counselling, grouped by intensity of intervention (very low certainty).
4 findings from 1 review
RR 1.52 [0.8, 2.89]
2 studies · 1417 participants
Very low
RR 1.27 [1.02, 1.58]
12 studies · 4432 participants
Moderate
RR 1.04 [0.9, 1.2]
7 studies · 4627 participants
Very low
Show 1 more finding
Quit at longest · smoking cessation in hospitalised patients
Pharmacotherapy plus counselling leads to higher quit at longest compared with no pharmacotherapy or placebo plus counselling (high certainty).
3 findings from 1 review
RR 1.33 [1.05, 1.67]
8 studies · 3838 participants
High
RR 1.11 [0.86, 1.43]
4 studies · 872 participants
Low
RR 1.29 [0.96, 1.75]
4 studies · 829 participants
Moderate
Mortality within the longest · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids showed no clear difference in all‐cause mortality (during the index hospital admission, or within… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Pulmonary complications (as defined by study authors, including pneumonia, embolism, reduced pulmonary function, prolonged ventilation, and pleural effusion, during the index hospital admission) · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids may leads to lower pulmonary complications (as defined by study authors, including… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Complete resolution of phimosis · boys up to 18 years old with phimosis
Topical corticosteroids may leads to higher long‐term complete resolution of phimosis compared with placebo or no treatment (low certainty).
1 finding from 1 review